GSA Capital Partners’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40K Sell
87,465
-101,711
-54% -$93.8K ﹤0.01% 1619
2025
Q4
$416K Buy
189,176
+10,153
+6% +$16.3K 0.04% 944
2025
Q3
$285K Buy
+179,023
New +$232K 0.02% 1233

Other funds holding GUTS

GSA Capital Partners's GUTS Position: Q1 2026 in Review

GSA Capital Partners reduced its Fractyl Health (GUTS) stake by 54% in Q1 2026, selling an estimated $93.8K and leaving 87,465 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

GSA Capital Partners first reported a position in GUTS in Q3 2025 and has held it in 3 quarters since. The position peaked at $416K in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • GSA Capital Partners held 87,465 shares of Fractyl Health worth $40K as of Q1 2026.
  • GSA Capital Partners sold 101,711 Fractyl Health shares in Q1 2026, an estimated $93.8K.
  • Fractyl Health made up ﹤0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1619 holding.
  • GSA Capital Partners first reported a position in Fractyl Health in Q3 2025 and has held it in 3 quarters since.
  • GSA Capital Partners's Fractyl Health position peaked at $416K in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.